Vaxcyte, Inc. [PCVX] - appoints John Markels as Director
Effective July 16, 2026, John Markels was appointed as a Class II director of Vaxcyte, Inc., succeeding Heath Lukatch, who is retiring after over eight years of service.
Why this matters
Generating analysis…